Multiple sclerosis and herpesvirus interaction;Esclerose múltipla e interação com os herpesvirus

Arquivos de Neuro-Psiquiatria

Volumn 71, Issue 9 B, 2013, Pages 727-730

  Olival, Guilherme Sciascia do ^a   Lima, Bruna Mendonça ^a   Sumita, Laura M ^b   Serafim, Vitor ^c   Fink, Maria Cristina ^b   Nali, Luis Henrique ^b   Romano, Camila Malta ^b   Thomaz, Rodrigo Barbosa ^a   Cavenaghi, Vitor Breseghello ^c   Tilbery, Charles Peter ^c   Penalva de Oliveira, Augusto Cesar ^c  

^a IRMANDADE DA SANTA CASA DE MISERICÓRDIA DE SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

Author keywords

Bmultiple sclerosis; Demyelinating disease; Herpesvirus

Indexed keywords

GADOLINIUM; IMMUNOGLOBULIN M ANTIBODY; MYELIN;

CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HERPES VIRUS; HERPES VIRUS TYPE 6; HUMAN; HUMAN HERPESVIRUS 7; LATENT PERIOD; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; REVIEW; SEROLOGY; T LYMPHOCYTE; VIRUS INFECTION; VIRUS PATHOGENESIS;

HERPESVIRIDAE INFECTIONS; HUMANS; MULTIPLE SCLEROSIS;

EID: 84885764934     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/0004-282X20130160     Document Type: Review

References (24)

1. Zuvich RL, Mccauley JL, Pericak-Vance MA, Haines JL. Genetics and pathogenesis of multiple sclerosis. Sem Immunol 2009; 21:328-333.
2. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007;61:288-299.
3. Voumvourakis KI, Dimitrios KK, Tsiodras S, Petrikkos G, Stamboulis E. Human herpesvirus 6 infection as a trigger of multiple sclerosis. Mayo Clin Proc 2010;85:1023-1030.
4. De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features and therapy. Clin Microbiol Rev 2005;18:217-245.
5. Pohl D, Krone B, Rostasy K. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 2006;67:2063-2065.
6. Levin LI, Munger K, O'Reilly EJ, Falk KI, Ascherio A. Primary infection with Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 2010;67:824-830.
7. De Lorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 2006;63:839-844.
8. Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis. J Am Med Assoc 2001; 286:3083-3088.
9. Lünemann JD, Kamradt T, Martin R, Münz C. Epstein-Barr virus: environmental trigger of multiple sclerosis? J Virol 2007;81:6777-6784.
10. Giovannoni G. Epstein-Barr virus and MS. Internat MS J 2011;17:44-49.
11. Dolei A, Serra C, Mameli G, et al. Multiple sclerosis associated retrovirus (MSRV) in Sardinian MS patients. Neurology 2002;58:471-473.
12. Serra C, Sotgiu S, Mameli G, Pugliatti M, Rosati G, Dolei A. Multiple sclerosis and multiple sclerosis associated retrovirus in Sardinia. Neurol Sci 2001;22:171-173.
13. Sotgiu S, Serra C, Mameli G. Multiple sclerosis associated retrovirus and MS prognosis: an observational study. Neurology 2002;5:1071-1073.
14. Perron H, Garson JA, Bedin F. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci U S A 1997;14:7583-7588.
15. do Olival GS, Faria TS, Nali LH, et al. Genomic analysis of ERVWE2 locus in patients with multiple sclerosis: absence of genetic ssociation but potential role of human endogenous retrovirus type W elements in molecular mimicry with myelin antigen. Front Microbiol 2013;4:172.
16. Antony JM, Van Marle G, Opii W. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocytes death and demyelination. Nature Neurosc 2004;7: 1088-1095.
17. Mameli G, Poddighe L, Mei A, et al. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. PLoS One 2012;7:e44991.
18. Sanadgol N, Ramroodi N, Ahmadi GA, et al. Prevalence of cytomegalovirus infection and its role in total immunoglobulin pattern in Iranian patients with different subtypesof multiple sclerosis. New Microbiol 2011;34:263-274.
19. Zivadinov R, Nasuelli D, Tommasi MA, Serafin M, Bratina A. Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis. J Neurol Res 2006;28:262-269.
20. Pirko I, Cardin R, Chen Y, et al. CMV infection attenuates the disease course in a murine model of multiple sclerosis. PLoS ONE 2012;7:1-7.
21. Nora-Krunkle Z, Chapenko S, Logina I, Millers A, Platkajis A, Murovska M. Human herpesvirus 6 and 7 and disease activity in multiple sclerosis. Medicina (Kaunas) 2011;47:527-531.
22. Opsahl ML, Kennedy PG. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 2005;128:516-527.
23. Opsahl ML, Kennedy PG. Investigating the presence of human herpesvirus 7 and 8 in multiple sclerosis and normal control brain tissue. J Neurol Sci 2006;240:37-44.
24. Knox KK, Brewer JH, Henry JM, Harrington DJ, Carrigan DR. Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease. Clin Infect Dis 2000;31:894-903.